K. Shackelford

Characterization of folate receptor from normal and neoplastic murine tissue: influence of dietary folate on folate receptor expression.

S. B. Gates, C. Shih, L. L. Habeck, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Drug treatments for metastasis of the Lewis lung carcinoma: lack of correlation between inhibition of lung metastasis and survival.

K. Matsumoto, K. Bemis, R. Merriman, 1989, Cancer Research.

The role of dietary folate in modulation of folate receptor expression, folylpolyglutamate synthetase activity and the efficacy and toxicity of lometrexol.

S. B. Gates, C. Shih, L. L. Habeck, 1996, Advances in enzyme regulation.

LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.

R M Schultz, S. B. Gates, R. Schultz, 1997, Cancer research.

Inhibition of anthrax lethal factor by ssDNA aptamers.

M. Yoon, Mieke Lahousse, Hae-Chul Park, 2018, Archives of biochemistry and biophysics.

The antiproliferative and cell cycle effects of 5,6,7, 8-tetrahydro-N5,N10-carbonylfolic acid, an inhibitor of methylenetetrahydrofolate dehydrogenase, are potentiated by hypoxanthine.

S. B. Gates, L. L. Habeck, J. Tonkinson, 1998, The Journal of pharmacology and experimental therapeutics.

A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors.

R. Schultz, C. Shih, L. L. Habeck, 1994, Cancer research.

The synthesis and biological activity of a series of 2,4-diaminopyrido[2,3-d]pyrimidine based antifolates as antineoplastic and antiarthritic agents.

S. B. Gates, R. Schultz, C. Shih, 1999, Bioorganic & medicinal chemistry letters.

Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.

S. B. Gates, C. Shih, L. L. Habeck, 1999, Seminars in oncology.